PINS Stimulator System for Deep Brain Stimulation to Treat Obesity
1 other identifier
interventional
8
0 countries
N/A
Brief Summary
The purpose of this clinical study is to verify the long term effecacy and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1 obesity
Started Dec 2016
Typical duration for early_phase_1 obesity
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2014
CompletedFirst Posted
Study publicly available on registry
October 1, 2014
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedOctober 14, 2016
August 1, 2016
2 years
September 29, 2014
October 13, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Body Weight
Body weight will be recorded at every follow-up visit.
12 month
Secondary Outcomes (2)
Body Mass Index (BMI)
12 month
Food Intake
12 month
Study Arms (2)
Deep Brain Stimulation
EXPERIMENTALStimulation is on.
Placebo
SHAM COMPARATORSham Stimulation: Stimulation is off.
Interventions
Eligibility Criteria
You may qualify if:
- Subject is aged 18 to 65.
- Body Mass Index \[BMI\] \>40 kg/m2.
You may not qualify if:
- Medical contraindications for general anesthesia, craniotomy, or DBS surgery
- Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas.
- Participate in other clinical trial;
- Has a life expectancy of \< 1 year.
- The investigator and/or enrollment review committee, would preclude participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Pins Medical Co., Ltdlead
- Beijing Tiantan Hospitalcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Li Luming, PhD
Tsinghua University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2014
First Posted
October 1, 2014
Study Start
December 1, 2016
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
October 14, 2016
Record last verified: 2016-08